Tissue-engineered bone formation with gene transfer and mesenchymal stem cells in a minimally invasive technique

Dongjoon Park, Jin Hyun Choi, Kam W. Leong, Jang Woo Kwon, Hee Seog Eun

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

BACKGROUND: The objective of this study was to use a chitosan-alginate gel to implant bone marrow-derived mesenchymal stem cells subcutaneously in a minimally invasive manner and promote bone formation by the simultaneously transferred osteogenic protein (OP)-1 (bone morphogenic protein-7) gene. METHOD AND RESULTS: The complex of polyethylenimine/luciferase plasmid DNA embedded in the gel was able to transfect HEK 293 cells on a culture dish or co-encapsulated in the gel. When injected into the subcutaneous space of mice, luciferase expression was two to three orders of magnitude increased above the background. To examine the efficacy of gene-, cell-, and combined gene- and cell-encapsulated gels in tissue generation, samples were injected into the subcutaneous space of 6-week-old athymic nude mice, and the OP-1 plasmid was studied. At 8 weeks after the injection, the gels only maintained their volumetric shape when human mesenchymal stem cells (hMSCs) were encapsulated, but otherwise the gels were partially dissolved. Transgene expression of OP-1 was clearly detected in the samples after 4 weeks but not after 8 weeks. Type II collagen was detected in all the gels containing the OP-1 plasmid, with or without hMSCs. The samples with the combination of OP-1 DNA and hMSCs revealed strong type II collagen expression as well as osteoid foci. CONCLUSION: These results suggest that combined gene and hMSC delivery within a chitosan-alginate gel could be an interesting approach for tissue engineering.

Original languageEnglish
Pages (from-to)1267-1271
Number of pages5
JournalLaryngoscope
Volume117
Issue number7
DOIs
Publication statusPublished - 2007 Jul 1

Fingerprint

Mesenchymal Stromal Cells
Osteogenesis
Gels
Bone Morphogenetic Protein 7
Genes
Plasmids
Collagen Type II
Chitosan
Luciferases
Nude Mice
Polyethyleneimine
HEK293 Cells
DNA
Tissue Engineering
Transgenes
Bone Marrow
Bone and Bones
Injections
Proteins

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Park, Dongjoon ; Choi, Jin Hyun ; Leong, Kam W. ; Kwon, Jang Woo ; Eun, Hee Seog. / Tissue-engineered bone formation with gene transfer and mesenchymal stem cells in a minimally invasive technique. In: Laryngoscope. 2007 ; Vol. 117, No. 7. pp. 1267-1271.
@article{21bdd41559df46669dd9897e646e7e86,
title = "Tissue-engineered bone formation with gene transfer and mesenchymal stem cells in a minimally invasive technique",
abstract = "BACKGROUND: The objective of this study was to use a chitosan-alginate gel to implant bone marrow-derived mesenchymal stem cells subcutaneously in a minimally invasive manner and promote bone formation by the simultaneously transferred osteogenic protein (OP)-1 (bone morphogenic protein-7) gene. METHOD AND RESULTS: The complex of polyethylenimine/luciferase plasmid DNA embedded in the gel was able to transfect HEK 293 cells on a culture dish or co-encapsulated in the gel. When injected into the subcutaneous space of mice, luciferase expression was two to three orders of magnitude increased above the background. To examine the efficacy of gene-, cell-, and combined gene- and cell-encapsulated gels in tissue generation, samples were injected into the subcutaneous space of 6-week-old athymic nude mice, and the OP-1 plasmid was studied. At 8 weeks after the injection, the gels only maintained their volumetric shape when human mesenchymal stem cells (hMSCs) were encapsulated, but otherwise the gels were partially dissolved. Transgene expression of OP-1 was clearly detected in the samples after 4 weeks but not after 8 weeks. Type II collagen was detected in all the gels containing the OP-1 plasmid, with or without hMSCs. The samples with the combination of OP-1 DNA and hMSCs revealed strong type II collagen expression as well as osteoid foci. CONCLUSION: These results suggest that combined gene and hMSC delivery within a chitosan-alginate gel could be an interesting approach for tissue engineering.",
author = "Dongjoon Park and Choi, {Jin Hyun} and Leong, {Kam W.} and Kwon, {Jang Woo} and Eun, {Hee Seog}",
year = "2007",
month = "7",
day = "1",
doi = "10.1097/MLG.0b013e31805f680e",
language = "English",
volume = "117",
pages = "1267--1271",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

Tissue-engineered bone formation with gene transfer and mesenchymal stem cells in a minimally invasive technique. / Park, Dongjoon; Choi, Jin Hyun; Leong, Kam W.; Kwon, Jang Woo; Eun, Hee Seog.

In: Laryngoscope, Vol. 117, No. 7, 01.07.2007, p. 1267-1271.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tissue-engineered bone formation with gene transfer and mesenchymal stem cells in a minimally invasive technique

AU - Park, Dongjoon

AU - Choi, Jin Hyun

AU - Leong, Kam W.

AU - Kwon, Jang Woo

AU - Eun, Hee Seog

PY - 2007/7/1

Y1 - 2007/7/1

N2 - BACKGROUND: The objective of this study was to use a chitosan-alginate gel to implant bone marrow-derived mesenchymal stem cells subcutaneously in a minimally invasive manner and promote bone formation by the simultaneously transferred osteogenic protein (OP)-1 (bone morphogenic protein-7) gene. METHOD AND RESULTS: The complex of polyethylenimine/luciferase plasmid DNA embedded in the gel was able to transfect HEK 293 cells on a culture dish or co-encapsulated in the gel. When injected into the subcutaneous space of mice, luciferase expression was two to three orders of magnitude increased above the background. To examine the efficacy of gene-, cell-, and combined gene- and cell-encapsulated gels in tissue generation, samples were injected into the subcutaneous space of 6-week-old athymic nude mice, and the OP-1 plasmid was studied. At 8 weeks after the injection, the gels only maintained their volumetric shape when human mesenchymal stem cells (hMSCs) were encapsulated, but otherwise the gels were partially dissolved. Transgene expression of OP-1 was clearly detected in the samples after 4 weeks but not after 8 weeks. Type II collagen was detected in all the gels containing the OP-1 plasmid, with or without hMSCs. The samples with the combination of OP-1 DNA and hMSCs revealed strong type II collagen expression as well as osteoid foci. CONCLUSION: These results suggest that combined gene and hMSC delivery within a chitosan-alginate gel could be an interesting approach for tissue engineering.

AB - BACKGROUND: The objective of this study was to use a chitosan-alginate gel to implant bone marrow-derived mesenchymal stem cells subcutaneously in a minimally invasive manner and promote bone formation by the simultaneously transferred osteogenic protein (OP)-1 (bone morphogenic protein-7) gene. METHOD AND RESULTS: The complex of polyethylenimine/luciferase plasmid DNA embedded in the gel was able to transfect HEK 293 cells on a culture dish or co-encapsulated in the gel. When injected into the subcutaneous space of mice, luciferase expression was two to three orders of magnitude increased above the background. To examine the efficacy of gene-, cell-, and combined gene- and cell-encapsulated gels in tissue generation, samples were injected into the subcutaneous space of 6-week-old athymic nude mice, and the OP-1 plasmid was studied. At 8 weeks after the injection, the gels only maintained their volumetric shape when human mesenchymal stem cells (hMSCs) were encapsulated, but otherwise the gels were partially dissolved. Transgene expression of OP-1 was clearly detected in the samples after 4 weeks but not after 8 weeks. Type II collagen was detected in all the gels containing the OP-1 plasmid, with or without hMSCs. The samples with the combination of OP-1 DNA and hMSCs revealed strong type II collagen expression as well as osteoid foci. CONCLUSION: These results suggest that combined gene and hMSC delivery within a chitosan-alginate gel could be an interesting approach for tissue engineering.

UR - http://www.scopus.com/inward/record.url?scp=34347345147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347345147&partnerID=8YFLogxK

U2 - 10.1097/MLG.0b013e31805f680e

DO - 10.1097/MLG.0b013e31805f680e

M3 - Article

VL - 117

SP - 1267

EP - 1271

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 7

ER -